|
JP2020127435A
|
|
Method for purifying and quantifying thrombin and its degradation polypeptides
|
|
US2020261492A1
|
|
Compositions Comprising Oxidized Cellulose
|
|
WO2020121290A1
|
|
High concentrated protein compositions for preventing tissue adhesion
|
|
IL268572D0
|
|
Expandable hemostat composed of oxidized cellulose
|
|
IL263679D0
|
|
Kits, methods, and compositions for preventing tissue adhesion
|
|
IL262716D0
|
|
Oxidized cellulose compositions
|
|
IL261190D0
|
|
Stable liquid thrombin compositions
|
|
IL256405D0
|
|
Wound dressing and a method for producing the same
|
|
IL256312D0
|
|
Antimicrobial compositions comprising minocycline and oxidized cellulose
|
|
IL256325D0
|
|
Antimicrobial compositions comprising minocycline and degradation products of oxidized cellulose
|
|
KR20190099476A
|
|
Hemostatic composition comprising an anion exchanger and calcium salt
|
|
IL255520D0
|
|
Powder dispensing applicator
|
|
AU2017328480A1
|
|
Stable pharmaceutical foam
|
|
IL249725D0
|
|
Hemostatic composition comprising an anion exchanger and a calcium salt
|
|
US2017157222A1
|
|
Thrombin microcapsules, preparation and uses thereof
|
|
RU2731371C2
|
|
Haemostatic mixture of short and long cellulose-based fibers
|
|
WO2017077526A1
|
|
Hemostatic mixture of cellulose-based short and long fibers
|
|
IL247821D0
|
|
Sealant formulations and uses thereof
|
|
IL247810D0
|
|
Stable pharmaceutical foam
|
|
IL244922D0
|
|
Device and process for sample preparation
|
